expiredsellsec_filings

COP 10-Q report for 2025-06-30

ConocoPhillips filed its Form 10‑Q for the quarter ended June 30, 2025. The filing contains interim (unaudited) consolidated financial statements—income statement, comprehensive income, balance sheet and cash flow statement—notes to the financials, and a Management’s Discussion & Analysis (table of contents). Key items disclosed include operating results for the three- and six-month periods, balance sheet and cash flow highlights, and details on the November 22, 2024 acquisition of Marathon Oil valued at $16.5 billion.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
failed

Linked assets

COP (ConocoPhillips) — quarterly SEC filing (Form 10‑Q) confirming reported Q2 2025 results, balance sheet and cash flow information; includes acquisition accounting and related notes.

COPsellfailed

ConocoPhillips (COP) Form 10‑Q for quarter ended June 30, 2025 — contains interim consolidated financial statements, notes and MD&A table of contents; reports results, balance sheet and cash flows and details of the Marathon Oil acquisition.

Confidence: 60 / 100Start: $92.60Latest: $121.57Return: -31.29%

The Form 10‑Q provides ConocoPhillips' unaudited consolidated financial statements for the three- and six-month periods ended June 30, 2025. Reported highlights from the filing include: total revenues and other income of $14,740 million for the three months and $31,841 million for the six months; net income of $1,971 million (Q2) and $4,820 million (six months); basic EPS of $1.56 (Q2) and $3.80 (six months); total assets of $122,599 million and total liabilities of $57,027 million as of June 30, 2025; net cash provided by operating activities of $9,600 million for the six months; and capital expenditures and investments of $6,664 million for the six months. The notes include details on inventories, acquisitions and dispositions (notably the November 22, 2024 acquisition of Marathon Oil valued at $16.5 billion), debt, contingent liabilities, and segment disclosures. The filing is primarily a factual reporting of results and disclosures; it confirms reported financial metrics and capital-structure items but does not itself present a new material catalyst beyond those reported figures and the acquisition accounting.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Source is ConocoPhillips’ Form 10‑Q for the quarter ended June 30, 2025 (Commission file number 001‑32395). The filing includes consolidated financial statements and notes, tables of contents for MD&A and risk factors, and schedules on acquisitions, inventories, debt and other accounting topics.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026 contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the company's filed Form 10‑Q; author count metadata indicates one author in the summary record.

Unlock full thesis monitoring

Expired play — recommended strategy: sell. Use the filed 10‑Q to validate reported figures, capital structure and acquisition disclosures; no new immediate trading catalyst is asserted by the filing itself.